表紙:タイロシンの世界市場:2021-2028年
市場調査レポート
商品コード
965968

タイロシンの世界市場:2021-2028年

Global Tylosin Market - 2021-2028

出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.25円
タイロシンの世界市場:2021-2028年
出版日: 2021年07月05日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界におけるタイロシン市場の成長は、畜産業におけるタイロシンの需要の高まりによって推進されています。タイロシンは、Brachyspira Hyodysenteriae (ブラキスピラ・ヒオディセンテリア:豚赤痢原因菌) に関連する豚赤痢の治療と管理、および豚の豚増殖性腸疾患の管理に使用されます。さらに、タイロシンは、タイロシン治療に繰り返し反応するイヌの慢性、再発性下痢であるタイロシン反応性下痢 (TRD) に非常に効果的です。

当レポートでは、世界のタイロシン市場について調査し、市場の概要、各セグメントおよび地域別による市場規模の予測、主要企業のプロファイル、競合情勢の分析など、体系的な情報を提供しています。

目次

第1章 世界のタイロシン市場:調査手法・調査範囲

  • 調査手法
  • 調査目的・調査範囲

第2章 世界のタイロシン市場:市場定義・概要

第3章 世界のタイロシン市場:エグゼクティブサマリー

  • 市場内訳:薬剤タイプ別
  • 市場内訳:アプリケーション別
  • 市場内訳:投与経路別
  • 市場内訳:地域別

第4章 世界のタイロシン市場:市場ダイナミクス

  • 市場影響要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 世界のタイロシン市場:業界要因

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 医療費償還分析
  • アンメットニーズ

第6章 世界のタイロシン市場:COVID-19分析

  • 市場でのCovid-19の分析
    • COVID-19以前の市場シナリオ
    • 現在の市場シナリオ
    • COVID-19以降または将来のシナリオ
  • Covid-19における価格のダイナミクス
  • 需要と供給のスペクトル
  • パンデミック時の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ
  • 結論

第7章 世界のタイロシン市場:薬剤タイプ別

  • イントロダクション
  • 市場規模分析と前年比成長分析(%):薬剤タイプセグメント別
  • 市場魅力指数:薬剤セグメント別
    • 酒石酸タイロシン
    • リン酸タイロシン
    • タイロシンベース
    • その他

第8章 世界のタイロシン市場:アプリケーション別

  • イントロダクション
  • 市場規模分析と前年比成長分析(%):アプリケーション別
  • 市場魅力指数:アプリケーション別
    • ネコ
    • イヌ
    • 家畜

第9章 世界のタイロシン市場:投与経路別

  • イントロダクション
  • 市場規模分析と前年比成長分析(%):投与経路別
  • 市場魅力指数:投与経路別
    • 経口
    • 注射剤

第10章 世界のタイロシン市場:地域別

  • イントロダクション
  • 市場規模分析・前年比成長率分析:地域別
  • 市場魅力指数:地域別
  • 北米
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析・前年比成長率分析:薬剤タイプ別
    • 市場規模分析・前年比成長率分析:アプリケーション別
    • 市場規模分析・前年比成長率分析:投与経路別
    • 市場規模分析・前年比成長率分析:国別
  • 欧州
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析・前年比成長率分析:薬剤タイプ別
    • 市場規模分析・前年比成長率分析:アプリケーション別
    • 市場規模分析・前年比成長率分析:投与経路別
    • 市場規模分析・前年比成長率分析:国別
  • 南米
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析・前年比成長率分析:薬剤タイプ別
    • 市場規模分析・前年比成長率分析:アプリケーション別
    • 市場規模分析・前年比成長率分析:投与経路別
    • 市場規模分析・前年比成長率分析:国別
  • アジア太平洋
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析・前年比成長率分析:薬剤タイプ別
    • 市場規模分析・前年比成長率分析:アプリケーション別
    • 市場規模分析・前年比成長率分析:投与経路別
    • 市場規模分析・前年比成長率分析:国別
  • 中東・アフリカ
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析・前年比成長率分析:薬剤タイプ別
    • 市場規模分析・前年比成長率分析:アプリケーション別
    • 市場規模分析・前年比成長率分析:投与経路別
    • 市場規模分析・前年比成長率分析:国別

第11章 世界のタイロシン市場:競合情勢

  • 競合シナリオ
  • 市場ポジショニング/シェア分析
  • 合併と買収の分析

第12章 世界のタイロシン市場:企業プロファイル

  • Zoetis
    • 企業概要
    • 製品ポートフォリオ・説明
    • 主なハイライト
    • 財務概要
  • Tairui Pharmaceuticals
  • Lukang Pharmaceutical
  • Henan Hualun
  • Qilu Pharmaceutical (Inner Mongolia) Co., Ltd
  • Huvepharma
  • AdvaCare Pharma
  • Elanco Animal Health
  • Apeloa Kangyu
  • Top Pharm Chemical Group

第13章 世界のタイロシン市場:重要考察

第14章 世界のタイロシン市場:DataM

  • 付録
  • 当社・サービスについて
  • お問い合わせ
目次
Product Code: DMPH2729

Market Overview

The global tylosin market size was worth US$ XX billion in 2018 and is estimated to reach US$ XX billion by 2027, growing at a CAGR of XX % during the forecast period (2020-2027).

Tylosin is an antibiotic of the macrolide class developed for veterinary use. Tylosin is licensed for use as a broad spectrum antibiotic for injectable or oral use in treatment of infection such as respiratory tract and skin infections in livestock. It may also be used as a growth promoter in food animals.

Market Dynamics

The global tylosin market growth is driven by the rising demand for tylosin in livestock industry. Tylosin is used for treatment and control of swine dysentery associated with Brachyspira Hyodysenteriae and for the control of porcine proliferate enteropathies in pigs. Moreover, Tylosin is highly effective in tylosin-responsive diarrhea in dogs, which is a canine chronic, recurrent diarrhea that responds repeatedly to tylosin treatment.

Increasing demand for tylosin in livestock industry is expected to propel growth

The global tylosin market is expected to witness significant growth over the forecast period, owing to rising demand for tylosin in livestock industry. For instance, according to a study by Ministry for Primary Industries, New Zealand 2016, tylosin accounted for over 83% of macrolide and lincosamide sales during 2011 and 2014 and the trend is expected to continue over the forecast period.

Antimicrobial medications are generally used in the livestock industry for treatment of various infections in the livestock, prevention of disease, and to improve growth rate of the animals efficiency. Moreover, antimicrobial medications have been found to be effective in animals for improving growth rate and increasing weight more efficiently, which in turn results in increasing profits for the meat producers.

Rising income levels and disposable income in emerging economies increase in demand

Rising income levels and disposable income in emerging economies has increase in demand for healthy protein sources for consumption as daily protein need of the body is not met through conventional food sources. According to NCBI, 2015, in Asia, the daily animal protein intake increased from 7 grams per capita per day to 25 grams per capita per day between 1960, and 2013. Countries such as Brazil, Russia, India, China, and South Africa (BRICS) have started implementing intensive livestock production systems to meet this demand (which necessitates use of antimicrobials). These factors are expected to support growth of the global Tylosin market over the forecast period.

The potential side effects associated with its use will hamper its market growth

The most common side effects of tylosin use include pain and inflammation at the injection site and mild gastrointestinal upset, such as decreased appetite and diarrhea. This short-acting medication should stop working within 24 hours, although effects can be longer in pets with liver or kidney disease.

COVID-19 Impact Analysis

The effects of COVID-19 on the livestock medications are still largely unquantified and yet to be fully felt. Movement restrictions and illness are resulting in tylosin shortages and reduced supply of raw materials or other API to its production. Disruption of supply routes has further delayed its supply. In China the world's biggest tylosin exporter restrictions have reduced its production in the factories by half, which could affect global trade flows. Thus, the pandemic has decreased the sale which hamper the global tylosin market in the forecast period.

Segment Analysis

Tylosin Tartrate segment is expected to grow at the fastest CAGR during the forecast period (2020-2028)

Tylosin tartrate is a particular type of antibiotic that is commonly used in a variety of animals, including dogs, cats, cattle, horses and more. This antibiotic serves a wide range of different purposes, but like other antibiotics it is designed specifically to target and kill certain types of bacteria. Without treating these bacteria, your pet may run the risk of developing an infection. In terms of its effects on animals. In dogs, tylosin tartrate is most commonly used to treat both gastric infections in general and colitis in particular. Colitis, which is characterized by irritable bowels and a lack of proper consistency in bowel movements, as well as excessive flatulence and general stomach upset, is caused by an influx of harmful bacteria in the gut and digestive tract. Regular treatments of tylosin tartrate have been shown to help eliminate this bacteria, particularly in smaller animals.

The demand for livestock animals for consumption is on the rise worldwide and is expected to maintain the positive growth in demand over the forecast period. Subsequently, the demand for infection-free and healthy livestock used primarily for consumption is increasing. However, the prevalence of various microbial infections is high in both humans and animals. For instance, according to the Centers for Disease Control and Prevention (CDC), 2017, zoonotic diseases are common in the U.S. and worldwide and over 6 out of every 10 known infectious diseases in humans are spread from animals. Hence, antibiotics are an important medication for livestock that aide in providing healthy food products for consumption in humans. This factor is driving the growth of the segment in the forecast period.

The livestock are expected to dominate the tylosin market during the forecast period

The major factors responsible for the growth of this segment include the efficiency of tylosin in various diseases or conditions, such as chronic respiratory disease (CRD) associated with Mycoplasma Gallisepticum and Mycolplasma synoviae and other infections.

According to National Center for Biotechnology Information (NCBI), 2015, around 80% of antibiotics sold in the U.S. are for livestock and almost 70% of these are medically important. Moreover, according to NCBI, the antimicrobial consumption in livestock is expected to increase by 67% by 2030, and nearly double. These factors are expected to boost the global Tylosin market growth over the forecast period.

Moreover, antibiotics such as tylosin are used in various animal species for prevention of mycoplasmosis. For instance, animals such as chickens, turkeys, pigs, and calves require oral Tylosin to be administered in required dosage to prevent mycoplasmosis and to grow healthy livestock. Furthermore, livestock is a major source of income in several of the emerging economies such as Brazil, which is major factor expected to contribute in growth of the market in the region over the forecast period.

Geographical Analysis

North America region holds the largest market share global tylosin market

North America region is dominating the global tylosin market accounted for the largest market share in 2019, owing to a wide range of definitive measures adopted by government animal welfare organizations that are consistently working for overall improvement in animal health.

Apart from the high prevalence of GI disorders, the changing lifestyle, unhealthy eating habits, and high disposable income are contributing to the high growth rates. On the other hand, Asia-Pacific is expected to exhibit the fastest growth rate over the forecast period. Furthermore, technological advancements, rising incidence of zoonotic diseases, and increasing number of pet owners are expected to boost the market in this country. Collaborative efforts undertaken by major companies to enhance their R&D capabilities and ensure high quality standards are also anticipated to impel demand across this region. Also, the steady importance given to agricultural contribution to these countries makes the owner more responsible for better care of farm animals. The healthcare expenditure compared to other countries, also fuels the market growth in North America. Thus, it should hold a major share of the market, over the forecast period.

Competitive Landscape

The tylosin market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Zoetis, Tairui Pharmaceuticals, Lukang Pharmaceutical, Henan Hualun, Qilu Pharmaceutical (Inner Mongolia) Co., Ltd, Huvepharma, AdvaCare Pharma, Elanco Animal Health, Apeloa Kangyu and Top Pharm Chemical Group among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the tylosin market globally.

Tylosin Market Key Companies to Watch

Elanco Animal Health

Overview: Elanco Animal Health Incorporated operates as an animal health care company. The Company develops, manufactures, and markets products for companion and food animals. Elanco Animal Health serves clients worldwide. Elanco Animal Health is located in BASINGSTOKE, United Kingdom and is part of the Pharmaceutical Manufacturing Industry. Elanco Animal Health has 49 employees at this location and generates $8.66 million in sales (USD).

Product Portfolio: The Company's portfolio comprised of Farm Animal Products & Services, Pet Animal Products & Services, and Care4Pigs.

Why Purchase the Report?

  • Visualize the composition of the tylosin market segmentation by drug type, application, and route of administration highlighting the key commercial assets and players.
  • Identify commercial opportunities in tylosin market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of tylosin market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global tylosin market report would provide an access to an approx. 60 market data table, 52 figures and 250 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Tylosin Market - Drug Type

  • Tylosin Tartrate
  • Tylosin Phosphate
  • Tylosin Base
  • Other

Global Tylosin Market - By Application

  • Felines
  • Canines
  • Livestock

Global Tylosin Market - By Route of Administration

  • Oral
  • Injectable

Global Tylosin Market - By Region

  • North America
  • South America
  • Europe
  • Asia
  • Middle East & Africa

Table of Contents

1. Global Tylosin Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Tylosin Market - Market Definition and Overview

3. Global Tylosin Market - Executive Summary

  • 3.1. Market Snippet by Drug Type
  • 3.2. Market snippet by Application
  • 3.3. Market Snippet by Route of Administration
  • 3.4. Market Snippet by Region

4. Global Tylosin Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing demand for tylosin in livestock industry
      • 4.1.1.2. Rising income levels and disposable income in emerging economies
    • 4.1.2. Restraints:
      • 4.1.2.1. Increasing antimicrobial resistance in livestock
      • 4.1.2.2. Potential side effects associated with its use
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Tylosin Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Unmet Needs

6. Global Tylosin Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Tylosin Market - By Drug Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type Segment
    • 7.1.2. Market Attractiveness Index, By Drug Segment
  • 7.2. Tylosin Tartrate *
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    • 7.2.2. Tylosin Phosphate
    • 7.2.3. Tylosin Base
    • 7.2.4. Other

8. Global Tylosin Market - By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Felines *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Canines
  • 8.4. Livestock

9. Global Tylosin Market - By Route of Administration

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration Segment
    • 9.1.2. Market Attractiveness Index, By Route of Administration Segment
  • 9.2. Oral*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 9.3. Injectable

10. Global Tylosin Market - By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration

11. Global Tylosin Market - Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of key companies to watch
  • 11.5. List of the company with disruptive technology
  • 11.6. List of start-up companies

12. Global Tylosin Market- Company Profiles

  • 12.1. Zoetis *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Tairui Pharmaceuticals
  • 12.3. Lukang Pharmaceutical
  • 12.4. Henan Hualun
  • 12.5. Qilu Pharmaceutical (Inner Mongolia) Co., Ltd
  • 12.6. Huvepharma
  • 12.7. AdvaCare Pharma
  • 12.8. Elanco Animal Health
  • 12.9. Apeloa Kangyu
  • 12.10. Top Pharm Chemical Group

LIST NOT EXHAUSTIVE

13. Global Tylosin Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us